BridgeBio Oncology Therapeutics, Inc. (BBOT): 4 filed Oct 5, 2026

Form type

4

Filing date

Oct 5, 2026

Accession number

0001193125-26-414135

Filer

BridgeBio Oncology Therapeutics, Inc. (CIK 1869105)